Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1958 1
1959 1
1962 1
1974 1
1975 4
1976 2
1977 1
1978 3
1979 8
1980 2
1981 2
1982 3
1983 3
1985 3
1986 2
1987 2
1989 1
1991 1
1992 4
1993 1
1994 1
1995 2
1996 3
1997 6
1998 4
1999 7
2000 7
2001 4
2002 18
2003 19
2004 22
2005 31
2006 38
2007 40
2008 65
2009 91
2010 104
2011 115
2012 113
2013 115
2014 127
2015 166
2016 161
2017 172
2018 202
2019 207
2020 249
2021 27
Text availability
Article attribute
Article type
Publication date

Search Results

1,915 results
Results by year
Filters applied: . Clear all
Page 1
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
Furie R, Rovin BH, Houssiau F, Malvar A, Teng YKO, Contreras G, Amoura Z, Yu X, Mok CC, Santiago MB, Saxena A, Green Y, Ji B, Kleoudis C, Burriss SW, Barnett C, Roth DA. Furie R, et al. Among authors: teng yko. N Engl J Med. 2020 Sep 17;383(12):1117-1128. doi: 10.1056/NEJMoa2001180. N Engl J Med. 2020. PMID: 32937045 Clinical Trial.
Plant-Derived Exosomal MicroRNAs Shape the Gut Microbiota.
Teng Y, Ren Y, Sayed M, Hu X, Lei C, Kumar A, Hutchins E, Mu J, Deng Z, Luo C, Sundaram K, Sriwastva MK, Zhang L, Hsieh M, Reiman R, Haribabu B, Yan J, Jala VR, Miller DM, Van Keuren-Jensen K, Merchant ML, McClain CJ, Park JW, Egilmez NK, Zhang HG. Teng Y, et al. Cell Host Microbe. 2018 Nov 14;24(5):637-652.e8. doi: 10.1016/j.chom.2018.10.001. Epub 2018 Oct 25. Cell Host Microbe. 2018. PMID: 30449315 Free PMC article.
Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.
Gu H, Chen Q, Yang G, He L, Fan H, Deng YQ, Wang Y, Teng Y, Zhao Z, Cui Y, Li Y, Li XF, Li J, Zhang NN, Yang X, Chen S, Guo Y, Zhao G, Wang X, Luo DY, Wang H, Yang X, Li Y, Han G, He Y, Zhou X, Geng S, Sheng X, Jiang S, Sun S, Qin CF, Zhou Y. Gu H, et al. Among authors: teng y. Science. 2020 Sep 25;369(6511):1603-1607. doi: 10.1126/science.abc4730. Epub 2020 Jul 30. Science. 2020. PMID: 32732280 Free PMC article.
Diagnosing and treating antiphospholipid syndrome: a consensus paper.
Limper M, de Leeuw K, Lely AT, Westerink J, Teng YKO, Eikenboom J, Otter S, Jansen AJG, V D Ree M, Spierings J, Kruyt ND, van der Molen R, Middeldorp S, Leebeek FWG, Bijl M, Urbanus RT. Limper M, et al. Among authors: teng yko. Neth J Med. 2019 Apr;77(3):98-108. Neth J Med. 2019. PMID: 31012427 Free article.
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
Fanouriakis A, Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I, Boletis J, Frangou E, Houssiau FA, Hollis J, Karras A, Marchiori F, Marks SD, Moroni G, Mosca M, Parodis I, Praga M, Schneider M, Smolen JS, Tesar V, Trachana M, van Vollenhoven RF, Voskuyl AE, Teng YKO, van Leew B, Bertsias G, Jayne D, Boumpas DT. Fanouriakis A, et al. Among authors: teng yko. Ann Rheum Dis. 2020 Jun;79(6):713-723. doi: 10.1136/annrheumdis-2020-216924. Epub 2020 Mar 27. Ann Rheum Dis. 2020. PMID: 32220834
Composition design and medical application of liposomes.
Li M, Du C, Guo N, Teng Y, Meng X, Sun H, Li S, Yu P, Galons H. Li M, et al. Among authors: teng y. Eur J Med Chem. 2019 Feb 15;164:640-653. doi: 10.1016/j.ejmech.2019.01.007. Epub 2019 Jan 7. Eur J Med Chem. 2019. PMID: 30640028 Review.
Is It Time to Start Transitioning From 2D to 3D Cell Culture?
Jensen C, Teng Y. Jensen C, et al. Among authors: teng y. Front Mol Biosci. 2020 Mar 6;7:33. doi: 10.3389/fmolb.2020.00033. eCollection 2020. Front Mol Biosci. 2020. PMID: 32211418 Free PMC article. Review.
PFKP Signaling at a Glance: An Emerging Mediator of Cancer Cell Metabolism.
Lang L, Chemmalakuzhy R, Shay C, Teng Y. Lang L, et al. Among authors: teng y. Adv Exp Med Biol. 2019;1134:243-258. doi: 10.1007/978-3-030-12668-1_13. Adv Exp Med Biol. 2019. PMID: 30919341 Review.
The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer.
De Mattos-Arruda L, Sammut SJ, Ross EM, Bashford-Rogers R, Greenstein E, Markus H, Morganella S, Teng Y, Maruvka Y, Pereira B, Rueda OM, Chin SF, Contente-Cuomo T, Mayor R, Arias A, Ali HR, Cope W, Tiezzi D, Dariush A, Dias Amarante T, Reshef D, Ciriaco N, Martinez-Saez E, Peg V, Ramon Y Cajal S, Cortes J, Vassiliou G, Getz G, Nik-Zainal S, Murtaza M, Friedman N, Markowetz F, Seoane J, Caldas C. De Mattos-Arruda L, et al. Among authors: teng y. Cell Rep. 2019 May 28;27(9):2690-2708.e10. doi: 10.1016/j.celrep.2019.04.098. Cell Rep. 2019. PMID: 31141692 Free PMC article.
Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol.
Teng YKO, Bruce IN, Diamond B, Furie RA, van Vollenhoven RF, Gordon D, Groark J, Henderson RB, Oldham M, Tak PP. Teng YKO, et al. BMJ Open. 2019 Mar 20;9(3):e025687. doi: 10.1136/bmjopen-2018-025687. BMJ Open. 2019. PMID: 30898822 Free PMC article.
1,915 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback